Abstract
Hirschsprung's disease (HD) can be associated with the development of neuroendocrine tumours such as medullary thyroid carcinoma (MTC). The RET proto-oncogene is the major gene responsible for both HD and MTC. Mutations in exon 10 (codons 609, 611, 618, 620) were found in patients with co-occurrence of HD and MTC. The aim of the study was to screen the MTC risk in patients with HD. The prospective and retrospective genetic analyses comprised 56 HD patients (41 males, 15 females, aged 0–47). The prospective subgroup of patients consisted of 34 patients (25 boys, 9 girls) operated on between June 2003 and December 2005. The retrospective subgroup comprised 22 patients (16 boys, 6 girls) of 194 patients who were operated on between December 1979 and May 2003, non-systematically chosen preferably for total colonic aganglionosis (TCA). DNAs were isolated from blood and resected segments of aganglionic bowel. The HD patients and nine available family members (2 HD) were tested for RET mutations in exons 10, 11, 13, 14, 15 and 16. Direct double-stranded fluorescent sequencing revealed typical germline heterozygous MTC risk RET mutations in 3/56 (5.4%) female HD patients: Cys609Tyr, Cys620Arg (both exon 10) and Tyr791Phe (exon 13). Two of these patients had TCA and one patient had classical type of HD. One TCA patient developed clinical stage of MTC and underwent total thyroidectomy (TTE). The other two RET positive HD patients (aged 7 and 25 years) are screened for calcitonin level and they are without TTE till now. Two family members (mothers of TCA patients) with detected RET mutation underwent prophylactic TTE with MTC finding. Results showed the benefit of systematic RET mutation screening in HD patients in order to identify the risk of MTC in preclinical stage of the disease in patients with HD and their family members. We recommend to investigate not only exon 10 but also exon 13.
Similar content being viewed by others
Abbreviations
- MTC:
-
Medullary, thyroid carcinoma
- HD:
-
Hirschsprung's disease
- RET:
-
Rearranged during transfection
- TCA:
-
Total colonic aganglionosis
- TTE:
-
Total thyroidectomy
References
Coran AG (2004) Hirschsprung's disease. In: Neill JA Jr, Grosfeld JL, Fonkalsrud EW, Coran AG, Caldamone AA (eds) Principles of pediatric surgery. Mosby, St. Louis, pp 573–586
Puri P (2000) Hirschsprung's disease: clinical generalities. In: Hollschneider AM, Puri P (eds) Hirschsprung's disease and allied disorders. Harwood academic publishers, Amsterdam, pp 129–136
Parisi MA, Kapur RP (2000) Genetics of Hirschsprung disease. Curr Opin Pediatr 12:610–617
Lantieri F, Griseri P, Ceccherini I (2006) Molecular mechanisms of RET-induced Hirschsprung pathogenesis. Ann Med 38:11–19
Edery P, Lyonnet S, Mulligan L, Pelet A, Dow E, Abel L, Holder S, Nihoul-Fekete C, Ponder BA, Munnich A (1994) Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature 367:378–380
Hansford JR, Mulligan LM (2000) Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis. J Med Genet 37:817–827
Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Mannelli M, Pacini F, Ponder BA, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells SA Jr, Marx SJ (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658–5671
Jindrichova S, Vlcek P, Bendlova B (2004) Genetic causes of the thyroid carcinomas. Cas Lek Cesk 143:664–668
Arighi E, Popsueva A, Innocenti DD, Borrello MG, Carniti C, Perala NM, Pierotti MA, Sariola H (2004) Biological effects of the dual phenotypic Janus mutation of ret co-segregating with both multiple endocrine neoplasia type 2 and Hirschsprung's disease. Mol Endocrinol 18:1004–1017
Pelet A, Geneste O, Edery P, Pasini A, Chappuis S, Atti T, Munnich A, Lenoir G, Lyonnet S, Billaud M (1998) Various mechanisms cause RET-mediated signalling defects in Hirschsprung's disease. J Clin Invest 101:1415–1423
Inoue K, Shimotake T, Inoue K, Tokiwa K, Iwai N (1999) Mutational analysis of the RET proto-oncogene in a kindred with multiple endocrine neoplasia type 2A and Hirschsprung's disease. J Pediatr Surg 34:1552–1554
Dvořáková S, Dvořáková K, Malíková M, Škába R, Vlček P, Bendlová B (2005) A novel Czech kindred with familial medullary thyroid carcinoma and Hirschsprung's disease. J Pediatr Surg 40:E1–E6
Romeo G, Ceccherini I, Celli J, Priolo M, Betsos N, Bonardi G, Seri M, Yin L, Lerone M, Jasonni V, Martucciello G (1998) Association of multiple endocrine neoplasia type 2 and Hirschsprung disease. J Intern Med 243:515–520
Sijmons RH, Hofstra RMW, Wijburg FA, Links TP, Zwierstra RP, Vermey A, Aronson DC, Tan-Sindhunata G, Brouwers-Smalbraak GJ, Maas SM, Buys CH (1998) Oncological implications of RET gene mutations in Hirschsprung's disease. Gut 43:542–547
Decker RA, Peacock ML, Watson P (1998) Hirschsprung disease in MEN2A: increased spectrum of RET exon 10 genotypes and strong genotype-phenotype correlation. Hum Mol Genet 7:129–134
Pasini B, Rossi R, Ambrosio MR, Zatelli MC, Gullo M, Gobbo M, Collini P, Aiello A, Pansini G, Trasforini G, degli Uberti EC (2002) RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease. Surgery 131:373–381
Borrego S, Eng C, Sanchez B, Saez ME, Navarro E, Antinolo G (1998) Molecular analysis of the ret and GDNF genes in a family with multiple endocrine neoplasia type 2A and Hirschsprung disease. J Clin Endocrinol Metab 83:3361–3364
Škába R, Dudorkinová D, Lojda Zd, Dvořáková H, Pýcha K, Kabelka M (1994) Kasai's rectoplasty in the treatment of Hirschsprung's disease and another types of colorectal dysganglionosis in children. Analysis of 94 cases. Pediatr Surg Int 9:503–506
Sasaki Y, Shimotake T, Go S, Iwai N (2001) Total thyroidectomy for hereditary medullary thyroid carcinoma 12 years after correction of Hirschsprung's disease. Eur J Surg 167:467–469
Pakarinen MP, Rintala RJ, Koivusalo A, Heikkinen M, Lindahl H, Pukkala E (2005) Increased incidence of medullary thyroid carcinoma in patients treated for Hirschsprung's disease. J Pediatr Surg 40:1532–1534
Fitze G, Schierz M, Bredow J, Saeger HD, Roesner D, Schackert HK (2002) Various penetrance of familial medullary thyroid carcinoma in patients with RET protooncogene codon 790/791 germline mutations. Ann Surg 236:570–575
Gimm O, Niederle BE, Weber T, Bockhorn M, Ukkat J, Brauckhoff M, Thanh PN, Frilling A, Klar E, Niederle B, Dralle H (2002) RET proto-oncogene mutations affecting codon 790/791: a mild form of multiple endocrine neoplasia type 2A syndrome? Surgery 132:952–959
Kim SM, Oh JT, Cho SH (2006) Hirschsprung's disease in Korea clinical experience of 233 cases in single tertiary medical center. Jpn Soc Pediatr Surg 43:385
Acknowledgments
We would like to thank all the subjects who participated in this study. This work was supported by IGA MH CR NR/7806-3 and GACR 301/06/P425. The Family 1 with Cys609Tyr mutation was published previously as a case report in the article of Dvořáková et al. [12].
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Škába, R., Dvořáková, Š., Václavíková, E. et al. The risk of medullary thyroid carcinoma in patients with Hirschsprung's disease. Pediatr Surg Int 22, 991–995 (2006). https://doi.org/10.1007/s00383-006-1785-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00383-006-1785-6